Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/112064
- Title:
- The Leukotriene B-4/BLT1 Axis Is a Key Determinant in Susceptibility and Resistance to Histoplasmosis
- Universidade de São Paulo (USP)
- Indiana University
- Universidade Estadual Paulista (UNESP)
- 1932-6203
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- National Institutes of Health (NIH)
- CNPq: 302097/2010-4
- National Institutes of Health (NIH)HL103777-04
- The bioactive lipid mediator leukotriene B-4 (LTB4) greatly enhances phagocyte antimicrobial functions against a myriad of pathogens. In murine histoplasmosis, inhibition of the LT-generating enzyme 5-lypoxigenase (5-LO) increases the susceptibility of the host to infection. In this study, we investigated whether murine resistance or susceptibility to Histoplasma capsulatum infection is associated with leukotriene production and an enhancement of in vivo and/or in vitro antimicrobial effector function. We show that susceptible C57BL/6 mice exhibit a higher fungal burden in the lung and spleen, increased mortality, lower expression levels of 5-LO and leukotriene B-4 receptor 1 (BLT1) and decreased LTB4 production compared to the resistant 129/Sv mice. Moreover, we demonstrate that endogenous and exogenous LTs are required for the optimal phagocytosis of H. capsulatum by macrophages from both murine strains, although C57BL/6 macrophages are more sensitive to the effects of LTB4 than 129/Sv macrophages. Therefore, our results provide novel evidence that LTB4 production and BLT1 signaling are required for a histoplasmosis-resistant phenotype.
- 21-Jan-2014
- Plos One. San Francisco: Public Library Science, v. 9, n. 1, 9 p., 2014.
- 9
- Public Library Science
- http://dx.doi.org/10.1371/journal.pone.0085083
- Acesso aberto
- outro
- http://repositorio.unesp.br/handle/11449/112064
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.